MedTrace Logo

Failure to Adjuvant Therapy After Pancreatic Resection for Pancreatic Cancer

NCT03788382 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 317

Last updated 2024-05-07

No results posted yet for this study

Summary

This study aims to evaluate the rate of patients submitted to pancreatic resection for pancreatic cancer, who fail to access to adjuvant therapy or do not complete adjuvant therapy. The purpose is to give an overview concerning the most frequent conditions and/or reasons associated with failure or omission of adjuvant therapy.

Conditions

  • Pancreatic Malignant Neoplasm Primary

Sponsors & Collaborators

  • Universita di Verona

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2024-02-28
Completion
2024-02-28

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03788382 on ClinicalTrials.gov